VK0214

· Viking Therapeutics, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VK0214, covering 2025-02-17 to 2025-02-17. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Assess the Pharmacodynamics of VK0214 in Male Subjects With AMN [Phase 1]